With respect to the correlation between high EC.SENESCENCE.SIG GSVA scores and a tumor-promoting dysbalance of immune cell infiltration of the tumors, we further hypothesized that this transcriptomic signature also offers the possibility to predict response to anti-PD-L1/PD-1 or anti-CTLA-4 immune checkpoint inhibitor therapy. Here, CD274 is linked to neoplasm.